[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Hwang Yoon-joo] The government will supply additional COVID-19 vaccines secured through a contract with Moderna to the domestic market.


According to the COVID-19 Vaccination Response Promotion Team (Promotion Team) on the 19th, 1,385,000 doses of Moderna vaccine will be shipped from Samsung Biologics' Songdo plant at 3 p.m. on the 20th. The vaccines supplied this time are part of the 40 million doses contracted directly.


It is also the first supply quantity after the Ministry of Food and Drug Safety granted manufacturing approval for Moderna Korea's COVID-19 vaccine.


Previously, the Moderna vaccines administered domestically were products of the U.S. Moderna company that had imported product approval.


Including the supply on the following day, the total number of Moderna vaccine doses introduced will increase to 21,697,000. This includes 450,000 doses received from Romania. Furthermore, including COVID-19 vaccines other than Moderna, a total of 105 million doses will have been supplied.


The vaccines secured by the government through contracts with individual pharmaceutical companies and international organizations or international cooperation include a total of 195.34 million doses from Moderna, Pfizer, AstraZeneca, Janssen, and Novavax.



Excluding 40 million doses of Novavax COVID-19 vaccine, which has not been approved for use domestically, the planned introduction quantity is 155.34 million doses, but about 50.34 million doses still need to be delivered within approximately two weeks by the end of the year.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing